ANGLE PLC (ANPCY)
1.89
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
ANGLE Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 1.218 |
| April 30, 2024 | 1.218 |
| April 29, 2024 | 1.218 |
| April 26, 2024 | 1.218 |
| April 25, 2024 | 1.218 |
| April 24, 2024 | 1.218 |
| April 23, 2024 | 1.218 |
| April 22, 2024 | 1.218 |
| April 19, 2024 | 1.218 |
| April 18, 2024 | 1.218 |
| April 17, 2024 | 1.218 |
| April 16, 2024 | 1.218 |
| April 15, 2024 | 1.218 |
| April 12, 2024 | 1.218 |
| April 11, 2024 | 1.218 |
| April 10, 2024 | 1.218 |
| April 09, 2024 | 1.160 |
| April 08, 2024 | 1.160 |
| April 05, 2024 | 1.160 |
| April 04, 2024 | 1.160 |
| April 03, 2024 | 1.160 |
| April 02, 2024 | 1.160 |
| April 01, 2024 | 1.160 |
| March 28, 2024 | 1.160 |
| March 27, 2024 | 1.160 |
| Date | Value |
|---|---|
| March 26, 2024 | 1.160 |
| March 25, 2024 | 1.160 |
| March 22, 2024 | 1.160 |
| March 21, 2024 | 1.160 |
| March 20, 2024 | 1.160 |
| March 19, 2024 | 1.160 |
| March 18, 2024 | 1.160 |
| March 15, 2024 | 1.160 |
| March 14, 2024 | 1.160 |
| March 13, 2024 | 1.160 |
| March 12, 2024 | 1.160 |
| March 11, 2024 | 1.276 |
| March 08, 2024 | 1.276 |
| March 07, 2024 | 1.276 |
| March 06, 2024 | 1.276 |
| March 05, 2024 | 1.276 |
| March 04, 2024 | 1.276 |
| March 01, 2024 | 1.276 |
| February 29, 2024 | 1.276 |
| February 28, 2024 | 1.276 |
| February 27, 2024 | 1.276 |
| February 26, 2024 | 1.276 |
| February 23, 2024 | 1.276 |
| February 22, 2024 | 1.276 |
| February 21, 2024 | 1.314 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7277
Minimum
Nov 27 2023
11.65
Maximum
Jul 01 2021
4.548
Average
4.225
Median
Nov 01 2022
Price to Book Value Benchmarks
| AstraZeneca PLC | 6.327 |
| Adaptimmune Therapeutics PLC | 7.496 |
| Biodexa Pharmaceuticals Plc | 0.9713 |
| Verona Pharma PLC | 4.931 |
| NuCana PLC | 0.4437 |
Price to Book Value Related Metrics
| Price | 1.89 |
| Market Cap | 49.25M |